Clinical Trials Logo

Pre-Gestational Diabetes clinical trials

View clinical trials related to Pre-Gestational Diabetes.

Filter by:
  • None
  • Page 1

NCT ID: NCT05909046 Recruiting - Clinical trials for Gestational Diabetes

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP)

Start date: July 24, 2023
Phase: N/A
Study type: Interventional

To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention) versus 4-12 week outpatient postpartum OGTT (current standard care) to improve the frequency of post-partum diabetes screening among individuals with a pregnancy complicated by GDM.

NCT ID: NCT05662462 Not yet recruiting - Type2diabetes Clinical Trials

Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching

Start date: May 2024
Phase: N/A
Study type: Interventional

The ACHIEVE RCT will measure the effect of the intervention (mHealth app with CGM, provider dashboard, and care team coaching) compared to current standard care (prenatal visits, self-monitored blood glucose, and certified diabetes care and education specialist) on achieving glycemic control (hemoglobin A1c <6.5% in the third trimester). We hypothesize a 25% absolute increase in the proportion of participants in the intervention group who will meet the target hemoglobin A1c <6.5% in the third trimester compared to the standard care group

NCT ID: NCT05410080 Recruiting - Clinical trials for Gestational Diabetes

the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome

Start date: June 15, 2022
Phase:
Study type: Observational

To determine and evaluate the diagnostic performance of Doppler sonography of umbilical artery (UA), fetal middle cereberal artery (MCA), ductus venosus (VD) and umbilical vein (UV) for prediction of adverse perinatal outcome among diabetic pregnant women.

NCT ID: NCT03574909 Not yet recruiting - Clinical trials for Pre-Gestational Diabetes

IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes

IRELAnD
Start date: September 2018
Phase: Phase 3
Study type: Interventional

To investigate the effect of aspirin therapy initiated in the first trimester of pregnancy in women with pregestational type I or type II diabetes on a composite clinical measure of placental dysfunction (preeclampsia, preterm birth less than 34 weeks, birthweight below the 10th centile or perinatal mortality).